Welcure Drugs (524661)
FAST GROWERScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6.99 |
| Market Cap | ₹55.47 Cr |
| P/E Ratio | 1.08 |
| ROCE | 2.53% |
| ROE | 34.77% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | -100% |
| 52-Week Range | ₹0.23 — ₹6.99 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹0.89 |
Welcure Drugs trades with a P/E ratio of 1.08, ROCE of 2.53%, ROE of 34.77%, profit growth of 1,000%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer